Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Clinical and Molecular Hepatology ; : 305-308, 2013.
Article in English | WPRIM | ID: wpr-127491

ABSTRACT

Autoimmune hepatitis (AIH) has been reported in association with Sjogren's syndrome (SS). Drug-induced AIH has been rarely reported. A rare case of the co-development of AIH and SS in a 53-year-old woman after the consumption of herbal medicines is described. After admission, the patient complained of dryness in her mouth, and she was subsequently diagnosed with SS, which had not been detected previously. The patient's bilirubin and aminotransferase levels initially decreased following conservative management; however, they later began to progressively increase. A diagnosis of AIH was made based on the scoring system proposed by the International Autoimmune Hepatitis Group. The patient was administered a combination of prednisolone and azathioprine, and the results of follow-up liver-function tests were found to be within the normal range. This is an unusual case of AIH and SS triggered simultaneously by the administration of herbal medicines.


Subject(s)
Female , Humans , Middle Aged , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Azathioprine/therapeutic use , Bilirubin/blood , Hepatitis, Autoimmune/complications , Herbal Medicine , Liver/pathology , Liver Function Tests , Prednisolone/therapeutic use , Sjogren's Syndrome/complications
2.
Korean Journal of Medicine ; : 813-816, 2012.
Article in Korean | WPRIM | ID: wpr-126591

ABSTRACT

Duloxetine is a balanced serotonin and norepinephrine reuptake inhibitor available for treating peripheral neuropathic pain. The occurrence of hyponatremia as an adverse event of duloxetine treatment, but it has not yet been reported in Korea. Here, we report two cases of hyponatremia induced by duloxetine for treatment of peripheral neuropathic pain. Our findings highlight the need for special attention when using duloxetine in elderly patients taking thiazide diuretics.


Subject(s)
Aged , Humans , Hyponatremia , Korea , Neuralgia , Norepinephrine , Serotonin , Selective Serotonin Reuptake Inhibitors , Sodium Chloride Symporter Inhibitors , Thiophenes , Duloxetine Hydrochloride
3.
Tuberculosis and Respiratory Diseases ; : 172-179, 2011.
Article in English | WPRIM | ID: wpr-182760

ABSTRACT

BACKGROUND: Statins can regulate the production of pro-inflammatory cytokines and inhibit MMP production or activation in a variety of types of cells. This study evaluated whether statins would inhibit MMP release from human lung fibroblasts, which play a major role in remodeling processes. METHODS: This study, using an in-vitro model (three-dimensional collagen gel contraction system), evaluated the effect of cytokines (tumor necrosis factor-alpha, TNF-a and interleukin-1beta, IL-1b) on the MMP release and MMP activation from human lung fibroblasts. Collagen degradation induced by cytokines and neutrophil elastase (NE) was evaluated by quantifying hydroxyproline. RESULTS: In three-dimensional collagen gel cultures (3D cultures) where cytokines (TNF-a and IL-1b) can induce the production of MMPs by fibroblasts, it was found that simvastatin inhibited MMP release. In 3D cultures, cytokines together with NE induced collagen degradation and can lead to activation of the MMP, which was inhibited by simvastatin. CONCLUSION: Simvastatin may play a role in regulating human lung fibroblast functions in repair and remodeling processes by inhibiting MMP release and the conversion from the latent to the active form of MMP.


Subject(s)
Humans , Airway Remodeling , Collagen , Contracts , Cytokines , Fibroblasts , Interleukin-1beta , Leukocyte Elastase , Lung , Matrix Metalloproteinases , Necrosis , Simvastatin
SELECTION OF CITATIONS
SEARCH DETAIL